Cancer

COVID-19 Pandemic Shifted Attitudes About Colorectal Cancer Screening

A survey of colorectal cancer screening patients found a preference for at-home fecal occult blood testing over colonoscopy during the COVID-19 pandemic.

Cancer

Nonagen’s Immunoassay Test Granted FDA Breakthrough Device Designation

Nonagen's non-invasive bladder cancer test has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation.

Cancer

More than BRCA: The other life-threatening breast cancer gene mutation to be aware of

Undergoing genetic testing Keri Forsythe-Stephens, learned she had a mutation of the gene, CHEK2, making her more susceptible to breast cancer.

Liquid Biopsy Testing Could be Key to HPV-Derived Cancer Detection

Sep 23, 2021 | Unknown Origin & Other Cancer Types

Investigators say high-risk human papillomaviruses DNA can be detected in the saliva of most patients with HR-HPV that leads to certain types of cancers.

British adults want blood tests which screen for cancer, study finds

Sep 22, 2021 | Cancer

A survey has found that 3 in 4 adults in the UK want more access to cancer screening, particularly as the COVID pandemic has begun to wane.

Genetic Testing Initiative Eyes Improving Healthcare

Sep 22, 2021 | Cancer, Cardiovascular

A genomics initiative called In Our DNA SC has been launched to improve health care outcomes by integrating genetic insights.

BioFluidica to Commericalize LiquidScan Biopsy System

Sep 21, 2021 | Leukemia, Microbiology Instruments, Prenatal Testing

BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.

What’s Next for Liquid Biopsy Tests?

Sep 20, 2021 | Lymphoma

Foresight Diagnostics CEO and CSO Jake Chabon gives an overview of what’s next for liquid biopsy testing, and how it will impact the continuum of care.

Thermo Fisher’s Oncomine Dx Receives FDA Premarket Approval

Sep 20, 2021 | Lung Cancer

The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic.

Photoacoustic Finder Helps Diagnose Metastatic Cancer

Sep 17, 2021 | Breast

A research team has developed a handheld photoacoustic finder that can help diagnose cancer without radiation exposure.

Liquid Biopsy Screening May Detect Breast Cancer Earlier

Sep 14, 2021 | Breast

AnchorDx has developed a new early breast cancer diagnostic model based on circulating cell-free DNA-based (cfDNA) methylation patterns.

Community Oncologists Use Biomarker Testing Less Than Academic Clinicians

Sep 14, 2021 | Lung Cancer

A recent report showed less than half of community oncologists used biomarker testing for lung cancer — compared to 73% of academic clinicians.

Data Shows Urine DNA Test Detects Bladder Cancer

Sep 14, 2021 | Unknown Origin & Other Cancer Types, Urine Analyzers

Promis Diagnostics recently presented data for CystoChek, a proprietary urine-based DNA methylation test of PENK for bladder cancer detection in hematuria.